Table 1.

Study and patient characteristics.

References	Year	Size	Age	PSA	Study type	Date type	Dose	TP (%)	FP (%)	FN (%)	TN (%)
Nanni et al. (11)	2015	50	67	3.2	Retrospective	Lesion-based	374 ± 19 MBq	89	31	11	69
Miller et al. (12)	2017	110	67.4	5.87 ng/ml	Retrospective	Patient-based	370 MBq	91	9	51	49
Calais et al. (13)	2018	10	70.8	1.0/1.1 ng/ml	Retrospective	Patient-based	371 MBq	20	63	80	37
Selnæs et al. (14)	2018	28	66.2	14.6 ng/ml	Retrospective	Lesion-based	370 MBq	40	60	0	100
						Patient-based		30	70	0	100
Suzuki et al. (15)	2019	28	67.3	88.6 ng/ml	Retrospective	Patient-based	185 MBq	57	43	15	85
Akin-Akintayo et al. (16)	2018	24	70.8	8.5 ng/ml	Prospective	Lesion-based	370 MBq	95	5	47	53
Elschot et al. (17)	2018	28	66	5.2 ng/ml	Prospective	Lesion-based	/	95	5	11	89
Jambor et al. (18)	2018	32	65	12.0 ng/ml	Retrospective	Patient-based	370 MBq	84	16	4	96
Odewole et al. (19)	2016	53	67.5	7.2 ng/ml	Retrospective	Lesion-based	358 MBq	70	30	23	77